Allergy medications that make you sleepy are a common concern for people managing hay fever, urticaria, or other allergic conditions in the UK. Many antihistamines — particularly older, first-generation medicines such as chlorphenamine and promethazine — are well known for causing drowsiness, which can affect driving, work, and daily life. However, not all allergy treatments carry the same sedation risk. Understanding which medications cause sleepiness, why they do so, and what non-drowsy alternatives exist can help you manage your allergies effectively without compromising your alertness or safety.

Why Some Allergy Medications Cause Drowsiness

First-generation antihistamines cause drowsiness by crossing the blood-brain barrier and blocking histamine receptors in the CNS that regulate wakefulness; second-generation antihistamines are far less likely to do this.

Not sure if this is normal? Chat with one of our pharmacists →

Antihistamines are the most commonly used allergy medications in the UK, and a significant number of them are well known for causing drowsiness. To understand why, it helps to look at how these medicines work. Histamine is a chemical released by the immune system in response to allergens such as pollen, pet dander, or dust mites. It binds to receptors throughout the body — including in the brain — triggering symptoms like sneezing, itching, and a runny nose.

First-generation antihistamines, such as chlorphenamine (Piriton) and promethazine, are able to cross the blood-brain barrier relatively easily. Once inside the central nervous system, they block histamine receptors in the brain that are involved in maintaining wakefulness and alertness. This central action is what produces the sedating effect. In fact, some of these medicines are deliberately used as short-term sleep aids or pre-operative sedatives because of this property.

In children, first-generation antihistamines can occasionally cause the opposite effect — paradoxical CNS stimulation, leading to excitability or agitation rather than drowsiness. Parents and carers should be aware of this possibility.

The degree of drowsiness varies between individuals and depends on factors including:

• Age — older adults and young children may be more sensitive to sedating effects

• Dose — higher doses increase the likelihood and severity of sedation

• Individual metabolism — genetic differences affect how quickly the drug is broken down

• Interactions — combining antihistamines with alcohol, opioids, or other sedatives significantly amplifies drowsiness

It is important to note that not all allergy medications cause sleepiness. Even antihistamines classified as 'non-drowsy' can affect some individuals, so patients should not drive or operate machinery until they know how any antihistamine affects them personally. Understanding the distinction between sedating and non-sedating options is key to choosing the most appropriate treatment for your circumstances.

For further information, the NHS provides a patient-facing overview of antihistamines, and the British National Formulary (BNF) contains detailed prescribing information including sedation profiles.

Sedating Antihistamines Available in the UK

Commonly available sedating antihistamines in the UK include chlorphenamine (Piriton), promethazine (Phenergan), and prescription-only hydroxyzine and alimemazine, all of which carry anticholinergic side effects and specific safety considerations.

Experiencing these side effects? Our pharmacists can help you navigate them →

Several sedating antihistamines are available in the UK, either over the counter (OTC) at pharmacies or on prescription. These are all first-generation antihistamines and are widely used for allergic conditions, though their sedating properties mean they require careful consideration before use.

Commonly available sedating antihistamines in the UK include:

• Chlorphenamine (Piriton) — available OTC; used for hay fever, hives, and insect bites. Age restrictions and licensed doses vary by product and formulation — always check the patient information leaflet (PIL) or summary of product characteristics (SmPC) for the specific brand. Many OTC tablet formulations are restricted to adults and older children.

• Promethazine (Phenergan) — available OTC for adults and children aged 2 years and over for certain indications; also used as a short-term sleep aid and for travel sickness. It must not be given to children under 2 years. Age restrictions and indications vary by formulation — always check the PIL/SmPC. The MHRA has issued safety communications regarding misuse of promethazine, particularly in young people, and risks of overdose.

• Hydroxyzine (Atarax, Ucerax) — prescription-only; used for anxiety as well as allergic conditions. The MHRA has issued a Drug Safety Update regarding hydroxyzine and the risk of QT interval prolongation. The maximum adult dose is 100 mg per day; it should be used at the lowest effective dose and avoided in older adults and in those with risk factors for QT prolongation (including electrolyte imbalances or concurrent use of other QT-prolonging medicines). Hydroxyzine is also contraindicated in pregnancy.

• Alimemazine (trimeprazine) — prescription-only; sometimes used in children for allergic conditions and as a pre-medication.

These medicines are generally effective at relieving allergy symptoms, and their sedating effect can occasionally be beneficial — for example, when itching is disrupting sleep. However, the sedation they cause is considered a side effect in most daytime use scenarios.

In children, paradoxical CNS stimulation (excitability or agitation) can occur with first-generation antihistamines and should be recognised as a possible adverse reaction.

Other common adverse effects of sedating antihistamines include:

• Dry mouth, nose, and throat

• Blurred vision

• Urinary retention (particularly in older men)

• Constipation

• Difficulty concentrating

Because of these anticholinergic effects, sedating antihistamines are generally not recommended as first-line treatment for most allergic conditions in adults, particularly where daytime functioning is important. The BNF and NICE guidance both acknowledge the limitations of first-generation antihistamines in routine allergy management.

If you experience a suspected side effect from any antihistamine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Non-Drowsy Alternatives and When to Consider Them

Non-drowsy antihistamines such as loratadine, fexofenadine, and cetirizine are recommended as first-line allergy treatment by NICE and the NHS, as they minimise sedation while effectively controlling symptoms.

Second-generation antihistamines were developed specifically to reduce the sedating effects associated with first-generation medicines. They are designed to have limited ability to cross the blood-brain barrier, meaning they act primarily on peripheral histamine receptors rather than those in the central nervous system. As a result, they are far less likely to cause drowsiness in most people.

Non-drowsy antihistamines widely available in the UK include:

• Cetirizine (Zirtek, Benadryl Allergy Relief) — OTC; effective for hay fever, urticaria, and perennial allergic rhinitis

• Loratadine (Clarityn) — OTC; well tolerated with a low sedation profile

• Fexofenadine (Telfast) — available OTC at 120 mg for hay fever; higher strengths are prescription-only. Considered one of the least sedating options.

• Bilastine — prescription-only in the UK; noted for minimal sedation. Important: bilastine must be taken on an empty stomach — at least one hour before or two hours after food. Fruit juices (including grapefruit, orange, and apple juice) reduce its absorption and should be avoided around the time of dosing, as confirmed in the bilastine SmPC.

• Desloratadine (Neoclarityn) — prescription-only; active metabolite of loratadine

NICE and NHS guidance generally recommend second-generation antihistamines as the first-line treatment for allergic rhinitis and urticaria in adults and older children, precisely because they allow patients to maintain normal daily functioning. They are taken once daily in most cases, which also supports adherence.

Unlike sedating antihistamines, second-generation agents may be used long-term when clinically indicated — for example, in persistent allergic rhinitis or chronic spontaneous urticaria — with periodic review by a clinician. This is in line with NICE Clinical Knowledge Summaries (CKS) for both allergic rhinitis and urticaria.

It is worth noting that cetirizine can cause mild drowsiness in some individuals, even though it is classified as non-sedating. Fexofenadine and loratadine tend to have the lowest sedation risk across the group. Even so, patients should not drive or operate machinery until they are confident that a particular antihistamine does not impair their alertness. If one non-drowsy antihistamine still causes tiredness, switching to an alternative within the same class — under pharmacist or GP guidance — may resolve the issue without sacrificing allergy control.

Risks of Drowsiness: Driving, Work, and Daily Activities

Sedating allergy medications can impair reaction times and concentration, making it illegal under UK law to drive if your ability is affected, with sedation potentially persisting into the following morning.

The drowsiness caused by sedating allergy medications carries real and potentially serious risks in everyday life. In the UK, it is a legal requirement under the Road Traffic Act 1988 and the drug driving legislation (2015) that drivers do not operate a vehicle if their ability to drive is impaired by medication. Sedating antihistamines such as chlorphenamine and promethazine can significantly impair reaction times, concentration, and decision-making — all of which are critical for safe driving.

The MHRA and the Driver and Vehicle Licensing Agency (DVLA) both advise that patients should not drive or operate heavy machinery if they are taking medicines that cause drowsiness. This applies even if the medication is purchased OTC without a prescription. Importantly, the sedating effect may persist into the following morning, meaning a dose taken the night before could still impair driving the next day — a risk that is often underestimated. Patients may find it helpful to track the timing of their dose and their alertness the following morning to identify any next-day impairment.

Even antihistamines classified as 'non-drowsy' can affect some individuals. The GOV.UK guidance on drugs and driving advises that you must not drive if a medicine impairs your ability to do so safely, regardless of whether it is a prescription or OTC product.

Beyond driving, drowsiness from allergy medications can affect:

• Workplace performance — reduced concentration, slower reaction times, and impaired judgement

• Academic performance — particularly relevant for students during hay fever season (spring and summer exam periods)

• Operating machinery — a significant occupational hazard in manual or industrial roles

• Childcare responsibilities — impaired alertness may affect the ability to supervise children safely

Alcohol substantially worsens the sedating effects of first-generation antihistamines and should be avoided entirely when taking them. Other CNS depressants — including opioids, benzodiazepines, and sedative medicines — also have additive effects and should not be combined with sedating antihistamines without medical advice. Even small amounts of alcohol can produce disproportionate sedation. Patients should always read the PIL supplied with their medication and heed all warnings regarding activities requiring alertness.

NHS and MHRA Guidance on Safe Use of Antihistamines

The NHS and MHRA advise not exceeding recommended doses, avoiding sedating antihistamines in older adults and certain medical conditions, and checking for interactions with alcohol, CNS depressants, and QT-prolonging medicines.

Both the NHS and the Medicines and Healthcare products Regulatory Agency (MHRA) provide clear guidance on the safe use of antihistamines, with particular attention to the risks associated with sedating formulations. The MHRA regularly reviews the safety profiles of medicines available in the UK and has issued specific Drug Safety Updates regarding antihistamine misuse — particularly concerning promethazine, which has been subject to warnings about misuse in young people and risks of overdose — and regarding hydroxyzine and the risk of QT interval prolongation.

Key safety points highlighted by NHS and MHRA guidance include:

• Do not exceed the recommended dose — higher doses increase sedation and the risk of adverse effects without meaningfully improving allergy control

• Avoid in certain populations — sedating antihistamines should be used with caution or avoided in older adults (due to falls risk, cognitive effects, and anticholinergic burden), and in those with conditions such as glaucoma, enlarged prostate, epilepsy, or cardiac conditions associated with QT prolongation. Hydroxyzine specifically carries an MHRA warning: use the lowest effective dose, do not exceed 100 mg per day in adults, avoid in older adults, and avoid in those with QT risk factors or electrolyte imbalances.

• Pregnancy and breastfeeding — all antihistamines should be used with caution during pregnancy and breastfeeding, and medical advice should be sought before use. Where treatment is considered necessary during pregnancy, loratadine or cetirizine are generally preferred based on available evidence (BNF, UKTIS, NHS guidance). Hydroxyzine is contraindicated in pregnancy. Women who are pregnant, breastfeeding, or planning a pregnancy should discuss their options with a GP or pharmacist.

• Check for interactions — antihistamines can interact with a range of other medicines. Key interactions include: alcohol and other CNS depressants (opioids, benzodiazepines, sedatives); monoamine oxidase inhibitors (MAOIs) with first-generation antihistamines; medicines that increase anticholinergic burden; and QT-prolonging drugs used alongside hydroxyzine. Bilastine absorption is reduced by food and fruit juices (see above). Always inform your pharmacist of all medicines you are taking, including supplements and herbal remedies.

• Duration of use — for acute allergic conditions, antihistamines are typically used for short-term symptom relief. However, second-generation (non-sedating) antihistamines may be used long-term for persistent conditions such as chronic spontaneous urticaria or perennial allergic rhinitis, in line with NICE CKS guidance, with periodic clinical review.

The NHS also recommends that patients with persistent or severe allergic conditions — such as chronic urticaria or severe hay fever — seek a formal review rather than relying solely on OTC antihistamines. Additional treatments, including intranasal corticosteroids (e.g., fluticasone, mometasone) and leukotriene receptor antagonists (e.g., montelukast), may be more appropriate and are available on prescription following NICE-aligned assessment.

If you experience a suspected side effect from any antihistamine or allergy medicine, please report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Talking to Your GP or Pharmacist About Your Options

A GP or pharmacist can help you choose the most appropriate allergy medication based on your symptoms, occupation, other medicines, and health conditions, and should be consulted if OTC antihistamines are inadequate or causing significant side effects.

Choosing the right allergy medication is not always straightforward, and both GPs and community pharmacists are well placed to help you make an informed decision based on your individual circumstances. In the UK, pharmacists are highly trained healthcare professionals who can advise on OTC allergy treatments without the need for a GP appointment — making them an accessible first point of contact for many people.

If you experience symptoms of anaphylaxis — such as swelling of the throat or tongue, difficulty breathing, a sudden drop in blood pressure, or loss of consciousness — call 999 immediately. If you have been prescribed an adrenaline auto-injector (such as an EpiPen), use it without delay. Antihistamines alone are not an appropriate treatment for anaphylaxis.

When speaking to a pharmacist or GP, it is helpful to share:

• Your specific allergy symptoms and how they affect your daily life

• Your occupation — particularly if you drive, operate machinery, or work in safety-critical roles

• Any other medicines you are currently taking, including supplements and herbal remedies

• Any existing health conditions, especially those affecting the heart, kidneys, liver, or urinary tract

• Whether you are pregnant, breastfeeding, or planning a pregnancy

You should contact your GP if:

• Your allergy symptoms are not adequately controlled by OTC antihistamines

• You experience significant side effects, including excessive drowsiness, confusion, palpitations, or signs of a paradoxical reaction in a child

• You require long-term allergy management or suspect you may have a more complex allergic condition

• You are considering antihistamines for a child under 2 years of age

• Your urticaria has persisted for more than six weeks (chronic spontaneous urticaria), as specialist assessment and guideline-supported up-dosing of non-sedating antihistamines may be appropriate

It may also be helpful to keep a note of when you take your antihistamine and how you feel the following morning, to help identify any next-day sedation and allow your clinician to tailor your regimen accordingly.

For those with severe or complex allergies, GP referral to an NHS allergy clinic may be appropriate. Specialist services can offer allergy testing, immunotherapy (desensitisation), and tailored management plans. The goal of any allergy treatment should be effective symptom control with minimal impact on quality of life — and with the right guidance, there is no reason why drowsiness should be an unavoidable consequence of managing your allergies.

Frequently Asked Questions